Dr. Mariam Alexander
Claim this profileMedical University of South Carolina
Expert in Non-Small Cell Lung Cancer
Studies Lung Cancer
15 reported clinical trials
25 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Mariam Alexander is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
More about Mariam Alexander
Clinical Trial Related3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Mariam Alexander has experience with
- Carboplatin
- Pembrolizumab
- Pemetrexed
- Paclitaxel
- Nivolumab
- Nab-paclitaxel
Breakdown of trials Mariam Alexander has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mariam Alexander specialize in?
Mariam Alexander focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Mariam Alexander currently recruiting for clinical trials?
Yes, Mariam Alexander is currently recruiting for 10 clinical trials in Charleston South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Mariam Alexander has studied deeply?
Yes, Mariam Alexander has studied treatments such as Carboplatin, Pembrolizumab, Pemetrexed.
What is the best way to schedule an appointment with Mariam Alexander?
Apply for one of the trials that Mariam Alexander is conducting.
What is the office address of Mariam Alexander?
The office of Mariam Alexander is located at: Medical University of South Carolina, Charleston, South Carolina 29425 United States. This is the address for their practice at the Medical University of South Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.